The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission-Reference-Cited by-同舟云学术

The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission

Published:2023-05 Issue:5 Volume:8 Page:458-492
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

Burisch Johan,Zhao Mirabella,Odes Selwyn,De Cruz Peter,Vermeire Severine,Bernstein Charles N,Kaplan Gilaad G,Duricova Dana,Greenberg Dan,Melberg Hans O,Watanabe Mamoru,Ahn Hyeong Sik,Targownik Laura,Pittet Valérie E H,Annese Vito,Park KT,Katsanos Konstantinos H,Høivik Marte L,Krznaric Zeljko,Chaparro María,Loftus Edward V,Lakatos Peter L,Gisbert Javier P,Bemelman Willem,Moum Bjorn,Gearry Richard B,Kappelman Michael D,Hart Ailsa,Pierik Marieke J,Andrews Jane M,Ng Siew C,D'Inca Renata,Munkholm Pia

Funder

Leona M. and Harry B. Helmsley Charitable Trust

Health Foundation Limburg

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference238 articles.

1. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017;Lancet Gastroenterol Hepatol,2020

2. The four epidemiological stages in the global evolution of inflammatory bowel disease;Kaplan;Nat Rev Gastroenterol Hepatol,2021

3. Epidemiology and natural history of inflammatory bowel diseases;Cosnes;Gastroenterology,2011

4. Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determining therapeutic goals for treat-to-target;Peyrin-Biroulet;Am J Gastroenterol,2015

5. Early biologic treatment versus conventional treatment for the management of Crohn's disease: a review of comparative clinical effectiveness and cost-effectiveness;Thompson,2019

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How Does an Integrated Pharmacist Add Value in the Management of Inflammatory Bowel Disease in the Era of Values-Based Healthcare?;Inflammatory Bowel Diseases;2024-08-29

2. Sodium orthovanadate protects against ulcerative colitis and associated liver damage in mice: insights into modulations of Nrf2/Keap1 and NF-κB pathways;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-08-09

3. The Costs of Home Monitoring by Telemedicine vs Standard Care for Inflammatory Bowel Diseases—A Danish Register-Based, 5-Year Follow-up Study;Journal of Crohn's and Colitis;2024-08-07

4. The Cost of Inflammatory Bowel Disease Care – How to Make it Sustainable;Clinical Gastroenterology and Hepatology;2024-08

5. The Role of Environmental and Nutritional Factors in the Development of Inflammatory Bowel Diseases: A Case–Control Study;Nutrients;2024-07-29